Symbiosis Pharmaceutical Services Ltd., a CMO and biopharmaceutical development services provider, has purchased new premises in Stirling, Scotland, UK.    The additional space will double the company’s total footprint across the four facilities that it will operate from, increasing manufacturing capacity by 50% in the short-term. As part of a wider strategic growth initiative, this move will strengthen the current GMP manufacturing service offering and further accelerate the delivery of steri...